Viewing Study NCT01947959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-01-10 @ 6:34 AM
Study NCT ID: NCT01947959
Status: COMPLETED
Last Update Posted: 2021-10-22
First Post: 2013-09-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thrombosis View
None Pulmonary Embolism View
None Atrial Fibrillation View
None Acute Coronary Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rivaroxaban View
None Stroke Prevention in Atrial Fibrillation View
None Anticoagulants View
None Hematologic Agents View
None Therapeutic Uses View
None Observational View
None Venous Thromboembolism View
None Secondary Prevention of Acute Coronary Syndrome View
None Intracranial Hemorrhages View
None Gastrointestinal Hemorrhage View